未登录

K

Krzysztof Sztanke

Medical University of Lublin

H指数:19

被引数:1,551

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Novel Fluorophenylated Dihydroimidazotriazinones as Potential Anticancer Agents: Design, Synthesis, In Vitro, Ex Vivo and In Silico Characterisation

新型氟苯基化二氢咪唑并三嗪酮作为潜在抗癌剂：设计、合成、体外、离体和计算机模拟表征

International Journal of Molecular Sciences

IF4.9

2026-09-200

OA

Potential drugs within a series of 3-phenylethyl-8-(R-phenyl)-7,8-dihydroimidazo[2,1-c][1,2,4]triazin-4(6H)-ones exhibit favourable toxicity profiles and thermal behaviours

3-苯乙基-8-(R-苯基)-7,8-二氢咪唑并[2,1-c][1,2,4]三嗪-4(6H)-酮系列中的潜在药物表现出有利的毒性和热行为

Scientific Reports

IF3.9

2026-09-030

OA

Application of Biomimetic IAM Chromatography and QSAR Modeling for Predicting Selected Properties of Potential Drugs and Plant Protection Products

生物仿生IAM色谱和QSAR建模在预测潜在药物和植物保护产品特定性质中的应用

Applied Sciences-Basel

IF2.5

2026-05-010

PRE

Influence of the structure of pharmacologically important hydrogenated heterofused triazines with an ester functional group on their melting points, thermal properties and decomposition path in inert and oxidizing conditions

JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY

IF3.1

2025-02-240

PRE

Biomimetic Chromatography/QSAR Investigations in Modeling Properties Influencing the Biological Efficacy of Phenoxyacetic Acid-Derived Congeners

IF4.6

2025-02-040

OAAI

Thermal Characterisation and Toxicity Profile of Potential Drugs from a Class of Disubstituted Heterofused Triazinones

IF4.6

2025-01-230

OAAI

First voltammetric analysis of two possible anticancer drug candidates using an unmodified glassy carbon electrode

SCIENTIFIC REPORTS

IF3.9

2024-07-270

OAAI

Modeling the Blood-Brain Barrier Permeability of Potential Heterocyclic Drugs via Biomimetic IAM Chromatography Technique Combined with QSAR Methodology

IF4.6

2024-01-056

OAAI

Thermal Investigations of Annelated Triazinones-Potential Analgesic and Anticancer Agents

IF4.6

2023-09-091

OAAI

Thermal Decomposition Path-Studied by the Simultaneous Thermogravimetry Coupled with Fourier Transform Infrared Spectroscopy and Quadrupole Mass Spectrometry-Of Imidazoline/Dimethyl Succinate Hybrids and Their Biological Characterization

IF3.2

2023-06-273

OAAI

TG-DSC and TG-FTIR Studies of Annelated Triazinylacetic Acid Ethyl Esters-Potential Anticancer Agents

IF4.6

2023-02-116

OAAI

Thermal properties and decomposition mechanism of disubstituted fused 1,2,4-triazoles considered as potential anticancer and antibacterial agents

JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY

IF3.1

2022-11-077

OA

Anti-Tumor Active Isopropylated Fused Azaisocytosine-Containing Congeners Are Safe for Developing Danio rerio as Well as Red Blood Cells and Activate Apoptotic Caspases in Human Breast Carcinoma Cells

IF4.6

2022-02-114

OAAI

Pyrolysis and oxidative decomposition mechanism of trifluoromethylated fused triazinones

JOURNAL OF ANALYTICAL AND APPLIED PYROLYSIS

IF6.2

2021-08-015

PREAI

Antioxidant Status in the Vitreous of Eyes with Rhegmatogenous Retinal Detachment with and without Proliferative Vitreoretinopathy, Macular Hole and Epiretinal Membrane

有或没有增生性玻璃体视网膜病变，黄斑裂孔和视网膜前膜的孔源性视网膜脱离眼玻璃体中的抗氧化状态

IF3.4

2021-05-1910

OAAI

Antioxidant Therapy in Inflammatory Bowel Diseases

IF6.6

2021-03-0960

OAAI

Anticancer active trifluoromethylated fused triazinones are safe for early-life stages of zebrafish (Danio rerio) and reveal a proapoptotic action

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

IF5.4

2021-01-044

OAAI

A Screen-Printed Sensor Coupled with Flow System for Quantitative Determination of a Novel Promising Anticancer Agent Candidate

IF3.5

2020-09-133

OAAI

Decomposition mechanism of annelated triazinones bearing the para-nitrophenyl group

JOURNAL OF ANALYTICAL AND APPLIED PYROLYSIS

IF6.2

2020-08-015

PREAI

Predicting the Blood-Brain Barrier Permeability of New Drug-Like Compounds via HPLC with Various Stationary Phases

IF4.6

2020-01-2325

OAAI